ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Suffering with BPH
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 144752" data-attributes="member: 13851"><p><span style="font-size: 26px"><strong>LARGE RETROSPECTIVELY MANAGED SINGLE SURGEON EXPERIENCE WITH PROSTATIC URETERAL LIFT.</strong></span></p><p></p><p><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=McMahon%20GC%5BAuthor%5D&cauthor=true&cauthor_uid=30950717" target="_blank">McMahon GC</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Panuganti%20S%5BAuthor%5D&cauthor=true&cauthor_uid=30950717" target="_blank">Panuganti S</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Wilson%20M%5BAuthor%5D&cauthor=true&cauthor_uid=30950717" target="_blank">Wilson M</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Thalody%20K%5BAuthor%5D&cauthor=true&cauthor_uid=30950717" target="_blank">Thalody K</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Mueller%20TJ%5BAuthor%5D&cauthor=true&cauthor_uid=30950717" target="_blank">Mueller TJ</a></p><p></p><p></p><p><a href="https://www.ncbi.nlm.nih.gov/pubmed/30950717" target="_blank">MP01-04 LARGE RETROSPECTIVELY MANAGED SINGLE SURGEON EXPERIENCE WITH PROSTATIC URETERAL LIFT. - PubMed - NCBI</a></p><p></p><p></p><p></p><p><span style="font-size: 18px"><strong>Abstract</strong></span></p><p></p><p><strong>INTRODUCTION AND OBJECTIVES: <span style="color: rgb(184, 49, 47)">Benign prostatic hyperplasia (BPH) </span>with associated <span style="color: rgb(184, 49, 47)">lower urinary tract symptoms (LUTS) </span>has a significant impact on quality of life</strong>. <strong><span style="color: rgb(184, 49, 47)">Multi-institutional projects </span>have demonstrated <span style="color: rgb(184, 49, 47)">Prostatic urethral lift (PUL) </span>as a <span style="color: rgb(184, 49, 47)">minimally invasive procedure </span>with strong <span style="color: rgb(184, 49, 47)">5-year durability, minimal side effect profile</span>, and no associated <span style="color: rgb(184, 49, 47)">erectile</span> or <span style="color: rgb(184, 49, 47)">ejaculatory dysfunction.</span> </strong>Long term single series data are needed. This studies purpose was to report on, to our knowledge, the largest single surgeon series of PUL.</p><p></p><p><strong>METHODS: </strong>We completed a retrospective chart review of men who underwent PUL in the office from June 2016 to May 2018. PUL, also known as Urolift (NeoTract, Pleasanton, CA, USA), was performed in the office by a single surgeon. International prostatic symptom score (IPSS), quality of life (QOL), and post void residuals (PVR) were recorded at baseline and at subsequent office visits. A paired-samples T-test was used to compare pre and post treatment values.</p><p></p><p><strong>RESULTS: </strong>We identified 156 men who had undergone a PUL. Descriptive statistics demonstrated an average age of 69 ± 11.9, prostate volume of 53.9 ± 29.1, number of implants used 5.5 ± 0.9, and post-operative catheter duration of 1.6 ± 1.8 days. When comparing IPSS, QOL, and PVR 151, 142, and 116 paired samples were available and the mean follow up period was 7.6 ± 5.8 [Range 0.5-24] months. IPSS values improved significantly 65% from 18.9 ± 7.4 to 6.7 ± 5.0 (-12.2 ± 7.7 p<0.05). QOL improved significantly 59% from 4.1 ± 1.3 to 1.7 ± 1.3 (-2.4 ± 1.7 p<0.05). Similarly, PVR decreased significantly 58% from 153.1 ± 232.8 to 64.2 ± 125.4 (-88.9 ± 150.6 p<0.05).</p><p></p><p><strong>CONCLUSIONS: </strong>To our knowledge, this is the largest single surgeon series reported on PUL.<strong> Our data demonstrated statistically <span style="color: rgb(184, 49, 47)">significant improvement</span> in <span style="color: rgb(184, 49, 47)">IPSS 65%, QOL 59%</span>, and <span style="color: rgb(184, 49, 47)">PVR 58%</span> at an average of <span style="color: rgb(184, 49, 47)">7.6 months.</span></strong> As our data set matures we hope to externally validate prior studies as well as report on patient group previous excluded from PUL, including patients in urinary retention, prostate volumes <30 or >80 grams, and having prior prostate interventions.</p></blockquote><p></p>
[QUOTE="madman, post: 144752, member: 13851"] [SIZE=26px][B]LARGE RETROSPECTIVELY MANAGED SINGLE SURGEON EXPERIENCE WITH PROSTATIC URETERAL LIFT.[/B][/SIZE] [URL='https://www.ncbi.nlm.nih.gov/pubmed/?term=McMahon%20GC%5BAuthor%5D&cauthor=true&cauthor_uid=30950717']McMahon GC[/URL], [URL='https://www.ncbi.nlm.nih.gov/pubmed/?term=Panuganti%20S%5BAuthor%5D&cauthor=true&cauthor_uid=30950717']Panuganti S[/URL], [URL='https://www.ncbi.nlm.nih.gov/pubmed/?term=Wilson%20M%5BAuthor%5D&cauthor=true&cauthor_uid=30950717']Wilson M[/URL], [URL='https://www.ncbi.nlm.nih.gov/pubmed/?term=Thalody%20K%5BAuthor%5D&cauthor=true&cauthor_uid=30950717']Thalody K[/URL], [URL='https://www.ncbi.nlm.nih.gov/pubmed/?term=Mueller%20TJ%5BAuthor%5D&cauthor=true&cauthor_uid=30950717']Mueller TJ[/URL] [URL='https://www.ncbi.nlm.nih.gov/pubmed/30950717']MP01-04 LARGE RETROSPECTIVELY MANAGED SINGLE SURGEON EXPERIENCE WITH PROSTATIC URETERAL LIFT. - PubMed - NCBI[/URL] [SIZE=18px][B]Abstract[/B][/SIZE] [B]INTRODUCTION AND OBJECTIVES: [COLOR=rgb(184, 49, 47)]Benign prostatic hyperplasia (BPH) [/COLOR]with associated [COLOR=rgb(184, 49, 47)]lower urinary tract symptoms (LUTS) [/COLOR]has a significant impact on quality of life[/B]. [B][COLOR=rgb(184, 49, 47)]Multi-institutional projects [/COLOR]have demonstrated [COLOR=rgb(184, 49, 47)]Prostatic urethral lift (PUL) [/COLOR]as a [COLOR=rgb(184, 49, 47)]minimally invasive procedure [/COLOR]with strong [COLOR=rgb(184, 49, 47)]5-year durability, minimal side effect profile[/COLOR], and no associated [COLOR=rgb(184, 49, 47)]erectile[/COLOR] or [COLOR=rgb(184, 49, 47)]ejaculatory dysfunction.[/COLOR] [/B]Long term single series data are needed. This studies purpose was to report on, to our knowledge, the largest single surgeon series of PUL. [B]METHODS: [/B]We completed a retrospective chart review of men who underwent PUL in the office from June 2016 to May 2018. PUL, also known as Urolift (NeoTract, Pleasanton, CA, USA), was performed in the office by a single surgeon. International prostatic symptom score (IPSS), quality of life (QOL), and post void residuals (PVR) were recorded at baseline and at subsequent office visits. A paired-samples T-test was used to compare pre and post treatment values. [B]RESULTS: [/B]We identified 156 men who had undergone a PUL. Descriptive statistics demonstrated an average age of 69 ± 11.9, prostate volume of 53.9 ± 29.1, number of implants used 5.5 ± 0.9, and post-operative catheter duration of 1.6 ± 1.8 days. When comparing IPSS, QOL, and PVR 151, 142, and 116 paired samples were available and the mean follow up period was 7.6 ± 5.8 [Range 0.5-24] months. IPSS values improved significantly 65% from 18.9 ± 7.4 to 6.7 ± 5.0 (-12.2 ± 7.7 p<0.05). QOL improved significantly 59% from 4.1 ± 1.3 to 1.7 ± 1.3 (-2.4 ± 1.7 p<0.05). Similarly, PVR decreased significantly 58% from 153.1 ± 232.8 to 64.2 ± 125.4 (-88.9 ± 150.6 p<0.05). [B]CONCLUSIONS: [/B]To our knowledge, this is the largest single surgeon series reported on PUL.[B] Our data demonstrated statistically [COLOR=rgb(184, 49, 47)]significant improvement[/COLOR] in [COLOR=rgb(184, 49, 47)]IPSS 65%, QOL 59%[/COLOR], and [COLOR=rgb(184, 49, 47)]PVR 58%[/COLOR] at an average of [COLOR=rgb(184, 49, 47)]7.6 months.[/COLOR][/B] As our data set matures we hope to externally validate prior studies as well as report on patient group previous excluded from PUL, including patients in urinary retention, prostate volumes <30 or >80 grams, and having prior prostate interventions. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Suffering with BPH
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top